Related Experiment Video

Updated: May 9, 2026

Chromogenic In Situ Hybridization as a Tool for HPV-Related Head and Neck Cancer Diagnosis
06:57

Chromogenic In Situ Hybridization as a Tool for HPV-Related Head and Neck Cancer Diagnosis

Published on: June 14, 2019

Immunotherapy of HPV-associated head and neck cancer: Critical parameters

Mevyn Nizard1, Federico Sandoval, Cecile Badoual

  • 1INSERM U970 PARCC; Université Paris Descartes; Paris, France.

Oncoimmunology
|July 30, 2013
PubMed

Insights

Developing a human papillomavirus (HPV) vaccine for HPV-associated head and neck cancer shows promise. However, challenges like tumor location and immune evasion must be addressed for effective immunotherapy.

Area of Science:

  • Oncology
  • Immunology
  • Virology

Background:

  • Human papillomavirus (HPV) is a major cause of head and neck cancers.
  • Current treatment strategies for HPV-associated head and neck cancer are limited.
  • Immunotherapy presents a potential treatment avenue.

Purpose of the Study:

  • To explore the rationale for developing an HPV vaccine for head and neck cancer treatment.
  • To identify key challenges hindering the efficacy of HPV-targeted immunotherapies.
  • To inform future strategies for improving treatment outcomes.

Main Methods:

  • Review of existing literature on HPV-associated head and neck cancer.
  • Analysis of tumor immunology and host-pathogen interactions.
  • Evaluation of potential therapeutic targets and challenges.

Main Results:

  • Strong scientific basis exists for an HPV vaccine in this context.
  • Mucosal tumor site presents unique challenges for drug delivery and immune response.
  • HPV-driven downregulation of MHC Class I and other immunosuppressive mechanisms impede anti-tumor immunity.

Conclusions:

  • An HPV vaccine is a viable strategy for HPV-associated head and neck cancer.
  • Overcoming immunosuppressive mechanisms and tumor localization is critical for clinical success.
  • Further research is needed to optimize immunotherapeutic approaches.
Keywords:
HPVPD1head and neckimmunotherapymucosal immunity

More Related Videos

Analysis of Human T Cell Activity in an Allogeneic Co-Culture Setting of Pre-Treated Tumor Cells09:04

Analysis of Human T Cell Activity in an Allogeneic Co-Culture Setting of Pre-Treated Tumor Cells

Published on: March 7, 2025

Four-color Fluorescence Immunohistochemistry of T-cell Subpopulations in Archival Formalin-fixed, Paraffin-embedded Human Oropharyngeal Squamous Cell Carcinoma Samples07:43

Four-color Fluorescence Immunohistochemistry of T-cell Subpopulations in Archival Formalin-fixed, Paraffin-embedded Human Oropharyngeal Squamous Cell Carcinoma Samples

Published on: July 29, 2017

Related Concept Videos

Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
Cancer Vaccines01:30

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...